Iris Simón
Eli Lilly (United States)(US)Universidad de Granada(ES)Eli Lilly (Netherlands)(NL)Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research(ES)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Estrogen and related hormone effects, Genetic factors in colorectal cancer, Epigenetics and DNA Methylation, Advanced Breast Cancer Therapies
Most-Cited Works
- → The consensus molecular subtypes of colorectal cancer(2015)5,121 cited
- → Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer(2010)538 cited
- → Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition(2013)350 cited
- → GTPase activity of Rab5 acts as a timer for endocytic membrane fusion(1996)326 cited
- → Rab GTPases, Directors of Vesicle Docking(1998)310 cited
- → Role of Rab9 GTPase in Facilitating Receptor Recruitment by TIP47(2001)259 cited